An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to detect clinically significant prostate cancer in high-risk patients, as reported in the medical journal Cancers on July 27, 2019.
Experts explain that the technology provides far more accurate readings than other models because it works at the level of ‘nanoparticles’. It also uses artificial intelligence to identify specific chemicals, or ‘biomarkers’, produced by a range of diseases. Previous devices have only been able to detect biomarkers when present in large quantities.
Alzheimer’s disease can only be definitely diagnosed after death when an autopsy conducted on the brain of the deceased reveals the accumulation of amyloid plaques between nerve cells (or neurons) in the brain.
North Korean leader Kim Jong-un has overseen the test-firing of a new type of “tactical guided weapon,” North Korean state media report, the first public test since the collapse of a second round of top-level negotiations between Washington and Pyongyang.